Literature DB >> 24048899

Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1).

Sang Hun Lee1, Javier A Carrero, Ravindra Uppaluri, J Michael White, Jessica M Archambault, Koon Siew Lai, Szeman Ruby Chan, Kathleen C F Sheehan, Emil R Unanue, Robert D Schreiber.   

Abstract

Although IFN-γ is required for resolution of Listeria monocytogenes infection, the identities of the IFN-γ-responsive cells that initiate the process remain unclear. We addressed this question using novel mice with conditional loss of IFN-γR (IFNGR1). Itgax-cre(+)Ifngr1(f/f) mice with selective IFN-γ unresponsiveness in CD8α(+) dendritic cells displayed increased susceptibility to infection. This phenotype was due to the inability of IFN-γ-unresponsive CD8α(+) dendritic cells to produce the initial burst of IL-12 induced by IFN-γ from TNF-α-activated NK/NKT cells. The defect in early IL-12 production resulted in increased IL-4 production that established a myeloid cell environment favoring Listeria growth. Neutralization of IL-4 restored Listeria resistance in Itgax-cre(+)Ifngr1(f/f) mice. We also found that Itgax-cre(+)Ifngr1(f/f) mice survived infection with low-dose Listeria as the result of a second wave of IL-12 produced by Ly6C(hi) monocytes. Thus, an IFN-γ-driven cascade involving CD8α(+) dendritic cells and NK/NKT cells induces the rapid production of IL-12 that initiates the anti-Listeria response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048899      PMCID: PMC3874833          DOI: 10.4049/jimmunol.1300910

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  A 25-kDa stretch of the extracellular domain of the human interferon gamma receptor is required for full ligand binding capacity.

Authors:  M Fountoulakis; H W Lahm; A Maris; A Friedlein; M Manneberg; D Stueber; G Garotta
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

2.  Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.

Authors:  R D Schreiber; L J Hicks; A Celada; N A Buchmeier; P W Gray
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

Authors:  K C Sheehan; N H Ruddle; R D Schreiber
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

Review 4.  Re(de)fining the dendritic cell lineage.

Authors:  Ansuman T Satpathy; Xiaodi Wu; Jörn C Albring; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2012-11-16       Impact factor: 25.606

5.  Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity.

Authors:  R C Fuhlbrigge; K C Sheehan; R D Schreiber; D D Chaplin; E R Unanue
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

6.  Analysis of the time course of IFN-gamma mRNA and protein production during primary murine listeriosis. The immune phase of bacterial elimination is not temporally linked to IFN production in vivo.

Authors:  R M Poston; R J Kurlander
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

7.  Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli.

Authors:  J C Wherry; R D Schreiber; E R Unanue
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

Authors:  G J Bancroft; K C Sheehan; R D Schreiber; E R Unanue
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

9.  Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Authors:  N A Buchmeier; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo.

Authors:  K A Hogquist; M A Nett; K C Sheehan; K D Pendleton; R D Schreiber; D D Chaplin
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

View more
  23 in total

Review 1.  Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection.

Authors:  William J Crisler; Laurel L Lenz
Journal:  Curr Opin Immunol       Date:  2018-06-07       Impact factor: 7.486

2.  T cell response kinetics determines neuroinfection outcomes during murine HSV infection.

Authors:  Aisha G Lee; Jason M Scott; Maria Rita Fabbrizi; Xiaoping Jiang; Dorothy K Sojka; Mark J Miller; Megan T Baldridge; Wayne M Yokoyama; Haina Shin
Journal:  JCI Insight       Date:  2020-03-12

Review 3.  The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.

Authors:  Douglas M Durrant; Soumitra Ghosh; Robyn S Klein
Journal:  ACS Chem Neurosci       Date:  2016-04-08       Impact factor: 4.418

4.  Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.

Authors:  Abigail E Overacre-Delgoffe; Maria Chikina; Rebekah E Dadey; Hiroshi Yano; Erin A Brunazzi; Gulidanna Shayan; William Horne; Jessica M Moskovitz; Jay K Kolls; Cindy Sander; Yongli Shuai; Daniel P Normolle; John M Kirkwood; Robert L Ferris; Greg M Delgoffe; Tullia C Bruno; Creg J Workman; Dario A A Vignali
Journal:  Cell       Date:  2017-05-25       Impact factor: 41.582

5.  Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation.

Authors:  Kelly M Cautivo; Peri R Matatia; Carlos O Lizama; Nicholas M Mroz; Madelene W Dahlgren; Xiaofei Yu; Julia Sbierski-Kind; Marcela T Taruselli; Jeremy F Brooks; Adam Wade-Vallance; Sofia E Caryotakis; Anthony A Chang; Hong-Erh Liang; Julie Zikherman; Richard M Locksley; Ari B Molofsky
Journal:  Immunity       Date:  2022-02-08       Impact factor: 31.745

6.  Memory-T-cell-derived interferon-γ instructs potent innate cell activation for protective immunity.

Authors:  Saïdi M'Homa Soudja; Ceena Chandrabos; Ernest Yakob; Mike Veenstra; Deborah Palliser; Grégoire Lauvau
Journal:  Immunity       Date:  2014-06-12       Impact factor: 31.745

Review 7.  Monocyte-mediated defense against bacteria, fungi, and parasites.

Authors:  Grégoire Lauvau; P'ng Loke; Tobias M Hohl
Journal:  Semin Immunol       Date:  2016-03-25       Impact factor: 11.130

Review 8.  Inflammatory monocyte effector mechanisms.

Authors:  Grégoire Lauvau; Laurent Chorro; Emily Spaulding; Saïdi M'Homa Soudja
Journal:  Cell Immunol       Date:  2014-08-14       Impact factor: 4.868

9.  Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive Streptococcus pneumoniae to Cause Deadly Pneumonia.

Authors:  Atul K Verma; Shruti Bansal; Christopher Bauer; Abenaya Muralidharan; Keer Sun
Journal:  J Immunol       Date:  2020-08-12       Impact factor: 5.422

10.  Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.

Authors:  Christopher S Garris; Sean P Arlauckas; Rainer H Kohler; Marcel P Trefny; Seth Garren; Cécile Piot; Camilla Engblom; Christina Pfirschke; Marie Siwicki; Jeremy Gungabeesoon; Gordon J Freeman; Sarah E Warren; SuFey Ong; Erica Browning; Christopher G Twitty; Robert H Pierce; Mai H Le; Alain P Algazi; Adil I Daud; Sara I Pai; Alfred Zippelius; Ralph Weissleder; Mikael J Pittet
Journal:  Immunity       Date:  2018-12-11       Impact factor: 43.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.